The import value of cyclan-, cyclen-, and cycloterpen-monocarboxylic acids to the US is projected to grow steadily from 2024 to 2028. The expected increase is from USD 183.14 million in 2024 to USD 195.37 million in 2028. This steady growth suggests an annual increase of around 1.6% over the five-year period, reflecting a consistent upward trend. Due to missing pre-2024 data, trend analysis for 2023 is not included.

Future trends to watch for:

Potential market fluctuations due to advancements in synthetic alternatives or new environmental regulations.
Exchange rate impacts, especially if international trade tensions escalate.
Changes in demand from end-user industries such as pharmaceuticals and natural products.